Dyne Therapeutics' DYNE-101 shows promising Phase 1/2 results for myotonic dystrophy type 1, with plans for Accelerated ...

Dyne Therapeutics (NASDAQ:DYN) reported clinical data from its ongoing Phase 1/2 trial of DYNE-101 in patients with myotonic dystrophy type 1. Shares down about 22% in early trade. DYNE-101 continued ...

(RTTNews) - Dyne Therapeutics, Inc. (DYN) Friday announced encouraging data from its ongoing Phase 1/2 ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1). Myotonic dystrophy ...

BBC News presenter Clive Myrie sparked a flurry of concerned messages on social media on Monday night after he appeared on ...

Connections with family and friends are key to living a happy, healthy life as an older adult. Electronic photo frames offer ways to share photos with those you love that appear immediately on their ...

Patients with myotonic dystrophy have smaller hearts, and lower systolic and diastolic blood pressures and pulse rates. They have impaired autonomic reflexes, measured by orthostatic, Valsalva ...

In 2023, the analyst reported a breakdown of Myotonic Dystrophy Type 1 cases in the US, with nearly 540 congenital, 3,893 infantile, 1,515 juvenile, 39,686 adult-onset, and 8,435late-onset cases.

Dec. 18, 2024 – Do the same treatments that help children focus and manage hyperactivity and attention problems also work for adults with attention deficit hyperactivity disorder (ADHD)?

A major review of evidence on ADHD treatment in adults has found stimulant drugs and one type of non-stimulant are the only effective treatments for reducing core symptoms of the condition.

A panel of independent health experts recommended Tuesday against older adults using vitamin D and calcium supplements to prevent falls and fractures, citing inadequate evidence to support their ...

Vitamin D and calcium are essential for overall health but don’t reduce the risk of falls or fractures in generally healthy older adults, according to a new draft recommendation from the US ...